Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma
Status:
NOT_YET_RECRUITING
Trial end date:
2031-12-31
Target enrollment:
Participant gender:
Summary
This phase III trial aims to evaluate the efficacy and safety of induction chemotherapy combined with serplulimab (induction/maintenance therapy) with omission of concurrent chemotherapy in patients with locally advanced nasopharyngeal carcinoma (LA-NPC).
Phase:
PHASE3
Details
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology